Area 1 (‘Economy’): Improve the productivity, resilience and competitiveness of European Animal Production
To cooperate with a multi-disciplinary group interested in the development of new diagnostic assays for both viral and bacterial infectious diseases in livestock farms.
BioAssays, was founded in 2013 as an associate SME to the Scientific Park in Madrid (PCM), to focus on the development of molecular and cell-based tools for the detection and treatment of infectious diseases in both humans and livestock. BioAssays is an emerging biotech company with 6 employees; its founder team has a demonstrated research expertise along several European research laboratories for more than 28 years in basic and translational R&D.
The Bioassays’ R&D branch is primarily focused on the development of molecular and cell-based tools for the detection and treatment of infectious diseases in both humans and livestock farms. Our ongoing R&D projects are performed in close collaboration with research teams in the Centro de Biologia Molecular Severo Ochoa (CBMSO-CSIC):
.- Development of in vitro diagnostic kits based on specific antibody recognition as well as multiplexed PCR-based assays to detect the infection by the African swine fever virus (ASFV). in pig exploitation.
.- Design and development of efficient prophylactic vaccines against the African swine fever virus (ASFV).
Moreover, and in collaboration with horse and pets veterinarians, BioAssays is also developing of multiplexed PCR-based assays for in vitro detection of Mycoplasma pneumoniae and Mycoplasma sp. as well as other bacteria strains from blood samples.
Bioassays is also a CRO dealing with R&D services to be effectively integrated in biomedicine and agrobiotechnology research projects. Currently, BioAssays' technology on Molecular and Cell Biology and Biochemistry procedures largely covers the shortcomings of several biomedicine and biotech laboratories.
Our scientific and technical team has a broad experience in developing and leading international research projects to cover the initial steps of discovery, compound screening and functional validation in a reliable, reproducible and cost-effective manner.